114
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort

ORCID Icon, , ORCID Icon, ORCID Icon, , , , , ORCID Icon, ORCID Icon, , , ORCID Icon, , , ORCID Icon, , ORCID Icon, , ORCID Icon, & show all
Pages 1887-1898 | Published online: 04 Aug 2020

References

  • CooperCB. Airflow obstruction and exercise. Respir Med. 2009;103(3):325–334. doi:10.1016/j.rmed.2008.10.02619071004
  • MyersJ, PrakashM, FroelicherV, DoD, PartingtonS, AtwoodJE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801. doi:10.1056/NEJMoa01185811893790
  • CelliBR, CoteCG, MarinJM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa02132214999112
  • RobertsMH, MapelDW, BruseS, PetersenH, NyunoyaT. Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease. Am J Epidemiol. 2013;178(7):1150–1160. doi:10.1093/aje/kwt08723928262
  • MobergM, VestboJ, MartinezG, et al. Validation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation. COPD. 2014;11(4):381–387. doi:10.3109/15412555.2013.83617124111845
  • CoteCG, Pinto-PlataVM, MarinJM, NekachH, DordellyLJ, CelliBR. The modified BODE index: validation with mortality in COPD. Eur Respir J. 2008;32(5):1269–1274. doi:10.1183/09031936.0013850718579541
  • WoodruffPG, BarrRG, BleeckerE, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811–1821. doi:10.1056/NEJMoa150597127168432
  • CouperD, LaVangeLM, HanM, et al. Design of the subpopulations and intermediate outcomes in COPD study (SPIROMICS). Thorax. 2014;69:491–494. doi:10.1136/thoraxjnl-2013-203897
  • MyersJ, BaderD, MadhavanR, FroelicherV. Validation of a specific activity questionnaire to estimate exercise tolerance in patients referred for exercise testing. Am Heart J. 2001;142(6):1041–1046. doi:10.1067/mhj.2001.11874011717610
  • GevenoisPA, De VuystP, de MaertelaerV, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1996;154:187–192. doi:10.1164/ajrccm.154.1.86806798680679
  • GrydelandTB, DirksenA, CoxsonHO, et al. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J. 2009;34(4):858–865. doi:10.1183/09031936.0016790819324952
  • VestboJ, HurdSS, AgustiAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
  • ZigmondAS, SnaithRP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x6880820
  • CooperCB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006;119(10):21–31. doi:10.1016/j.amjmed.2006.08.00416996896
  • MorleyJE, HarenMT, RollandY, KimMJ. Frailty. Med Clin North Am. 2006;90(5):837–847. doi:10.1016/j.mcna.2006.05.01916962845
  • FriedLP, TangenCM, WalstonJ, et al. Frailty in older adults: evidence for a phenotype. J Gerontol a Biol Sci Med Sci. 2001;56(3):M146–M156. doi:10.1093/gerona/56.3.M14611253156
  • Abellan van KanG, RollandYM, MorleyJE, VellasB. Frailty: toward a clinical definition. J Am Med Dir Assoc. 2008;9(2):71–72. doi:10.1016/j.jamda.2007.11.00518261696
  • KirbyM, PikeD, SinDD, CoxsonHO, McCormackDG, ParragaG. COPD: do Imaging Measurements of emphysema and airway disease explain symptoms and exercise capacity? Radiology. 2015;277(3):872–880. doi:10.1148/radiol.201515003726151081
  • BernardP, NinotG, MoullecG, GuillaumeS, CourtetP, QuantinX. Smoking cessation, depression, and exercise: empirical evidence, clinical needs, and mechanisms. Nicotine Tob Res. 2013;15(10):1635–1650. doi:10.1093/ntr/ntt04223535556
  • De Miguel DíezJ, HernandezBV, PuenteML, CarrascoGP, GomezGT, JimenezGR. Prevalence of anxiety and depression among chronic bronchitis patients and the associated factors. Respirology. 2011;16(7):1103–1110. doi:10.1111/j.1440-1843.2011.02015.x21707853
  • QuintJK, Baghai-RavaryR, DonaldsonGC, WedzichaJA. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008;32(1):53–60. doi:10.1183/09031936.0012010718321938
  • Paz-DiazH, Montes de OcaM, LopezJM, CelliBR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2007;86:30–36. doi:10.1097/PHM.0b013e31802b8eca17304686
  • FletcherC, PetoR. The natural history of chronic airflow obstruction. Br Med J. 1977;1:1645–1648. doi:10.1136/bmj.1.6077.1645871704
  • HanMK, AgustiA, CalverleyPM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182:598–604. doi:10.1164/rccm.200912-1843CC20522794